Abstract P5-10-01: Phase 2 Study of Anlotinib Combined with Taxanes and Lobaplatin in the Neoadjuvant Treatment of Triple-Negative Breast Cancer: Efficacy, Safety and Biomarker Analysis from the SWH-B006 (neoaltall) Trial
Cancer Research（2023）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined